Does Anemia or Low Platelets Preclude the Use of an Approved JAK2 Inhibitor?

patientpower has 2382 videos Subscribe Here

Description: Anemia, low red cell count, and low platelets can be worrisome for patients with myelofibrosis and their doctors. It can happen when a new JAK2 inhibitor medicine is used. But in the opinion of a leading researcher, Dr. Srdan Verstovsek, these conditions should not lead to stopping use of the JAK2. He explains why in this interview with Patient Power's Andrew Schorr.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 04/26/13
Added : 5 years ago
Category : General